natgillin/translations-raw huggingface dataset:
Aktive stoffer: clopidogrel og acetylsalicylsyre.
The active substances are clopidogrel and acetylsalicylic acid.
Aktive stoffer: dapagliflozin og metforminhydrochlorid (metformin HCl).
The active substances are dapagliflozin and metformin hydrochloride (metformin HCl).
Aktive stoffer: desloratadin og pseudoephedrinsulfat
The active substances are desloratadine and pseudoephedrine sulphate.
Aktive stoffer: dolutegravir, abacavir og lamivudin.
The active substances are dolutegravir, abacavir and lamivudine.
Aktive stoffer: efavirenz, emtricitabin og tenofovirdisoproxil.
The active substances are efavirenz, emtricitabine and tenofovir disoproxil.
Aktive stoffer: elbasvir og grazoprevir.
The active substances are: elbasvir and grazoprevir.
Aktive stoffer: emodepsid 0,9 ml toltrazuril 18 mg.
Active substances: emodepside 0.9 mg, toltrazuril 18 mg
Aktive stoffer: emtricitabin og tenofovirdisoproxil.
The active substances are emtricitabine and tenofovir disoproxil.
Aktive stoffer: emtricitabin og tenofovirdisoproxilphosphat.
The active substances are emtricitabine and tenofovir disoproxil phosphate.
Aktive stoffer: emtricitabin, rilpivirin og tenofovirdisoproxil.
The active substances are emtricitabine, rilpivirine and tenofovir disoproxil.
Aktive stoffer: fenofibrat og pravastatin.
The active substances are fenofibrate and pravastatin.
Aktive stoffer: fluticasonfuroat og vilanterol.
The active substances are fluticasone furoate and vilanterol.
Aktive stoffer: follitropin alfa og lutropin alfa.
The active substances are follitropin alfa and lutropin alfa.
Aktive stoffer: human fibrinogen (5,5 mg/cm2) og human thrombin (2,0 IE/cm2)
The active substances are human fibrinogen (5.5 mg per cm2) and human thrombin (2.0 IU per cm2).
Aktive stoffer: Hver tablet indeholder 12,5 mg ombitasvir, 75 mg paritaprevir og 50 mg ritonavir.
Each tablet contains 12.5 mg of ombitasvir, 75 mg of paritaprevir and 50 mg of ritonavir.
Aktive stoffer: højtrenset ikke-smitsomt protein for hver af human papillomavirus-typerne (6, 11, 16 og 18).
The active substances are: highly purified non-infectious protein for each of the Human Papillomavirus types (6, 11, 16, and 18).
Aktive stoffer: insulin degludec og insulin aspart.
The active substances are insulin degludec and insulin aspart.
Aktive stoffer: insulin degludec og liraglutid.
The active substances are insulin degludec and liraglutide.
Aktive stoffer: Irbesartan og hydrochlorthiazid
The active ingredients are irbesartan and hydrochlorothiazide.
Aktive stoffer: irbesartan og hydrochlorthiazid
The active substances are irbesartan and hydrochlorothiazide.
Aktive stoffer: irbesartan og hydrochlorthiazid.
The active substances are irbesartan and hydrochlorothiazide.
Aktive stoffer: lamivudin og raltegravir.
The active substances are lamivudine and raltegravir.
Aktive stoffer: ledipasvir og sofosbuvir.
The active substances are ledipasvir and sofosbuvir.
Aktive stoffer: Linagliptin og metformin.
The active substances are linagliptin and metformin.
Aktive stoffer: Lopinavir og ritonavir.
The active substances are lopinavir and ritonavir
Aktive stoffer: Nicotinsyre og laropiprant.
The active substances are nicotinic acid and laropiprant.
Aktive stoffer: nomegestrolacetat og estradiol.
The active substances are: nomegestrol acetate and estradiol
Aktive stoffer: palonosetron og netupitant.
The active substances are palonosetron and netupitant.
Aktive stoffer: pioglitazon (som hydrochlorid) og metforminhydrochlorid.
The active substances are pioglitazone and metformin hydrochloride.
Aktive stoffer: salmeterol og fluticasonpropionat.
The active substances are salmeterol and fluticasone propionate.
Aktive stoffer: saxagliptin og dapagliflozin
The active substances are saxagliptin and dapagliflozin.
Aktive stoffer: Sitagliptin og metformin.
The active substances are sitagliptin and metformin.
Aktive stoffer: sofosbuvir og velpatasvir.
The active substances are sofosbuvir and velpatasvir.
Aktive stoffer: tasonermin.
The active substance is tasonermin.
Aktive stoffer: Tegafur, gimeracil og oteracil.
The active substances are tegafur, gimeracil and oteracil.
Aktive stoffer: telmisartan og amlodipin.
The active substances are telmisartan and amlodipine.
Aktive stoffer: Travoprost og timolol.
The active substances are Travoprost and timolol.
Aktive stoffer: Trifluridin og tipiracil.
The active substances are trifluridine and tipiracil.
Aktive stoffer: vildagliptin og metforminhydrochlorid.
The active substances are vildagliptin and metformin hydrochloride.
Aktive substanser der kan reducere gefitinibs plasmakoncentration
Active substances that may reduce gefitinib plasma concentrations
Aktive substanser der kan reducere plasmakoncentration af dasatinib
Active substances that may decrease dasatinib plasma concentrations
Aktive substanser der kan øge gefitinibs plasmakoncentration
Active substances that may increase gefitinib plasma concentrations
Aktive substanser der kan øge plasmakoncentrationer af dasatinib
Active substances that may increase dasatinib plasma concentrations
Aktive substanser, der kan nedsætte plasmakoncentrationen af osimertinib
Active substances that may decrease osimertinib plasma concentrations
Aktive substanser, der kan øge plasmakoncentrationen af osimertinib
Active substances that may increase osimertinib plasma concentrations
Aktive substanser, hvis plasmakoncentration kan ændres af Tagrisso
Active substances whose plasma concentrations may be altered by TAGRISSO
Aktive substanser, hvis plasmakoncentration kan ændres gefitinib
Active substances that may have their plasma concentrations altered by gefitinib
Aktive systemiske infektioner
Active systemic infections.
Aktiver ikke den lilla 20 mikrogram Lyxumia-pen før du har opbrugt den grønne pen
Do not activate the purple 20 microgram Lyxumia pen until you have finished the green pen.
Aktiver kanylens sikkerhedsbeskyttelse ved hjælp af en af de to viste metoder:
Activate the safety guard over the needle, in one of the two methods shown:
Aktiver kanylens sikkerhedsbeskyttelse ved hjælp af en af de to viste metoder: tryk enten det hængslede stykke af sikkerhedsbeskyttelsen ned mod en hård overflade (figur A), eller skub hængslet fremover med fingeren (figur B).
Activate the safety guard over the needle, in one of the two methods shown: either press the hinged section of the safety guard down onto a hard surface (figure A), or push the hinge forward with your finger (figure B).
Aktiver pennen samme dag som du får din første injektion
Activate the pen on the same day as your first injection
Aktiver pennen samme dag som du får din første injektion
Activate the pen on the same day as your first injection.
Aktiveres af synligt lys.
Is activated by visible light
Aktiveret koagulationstid (ACT) i op til 24 timer
Activated Clotting Time (ACT) for up to 24 hours,
Aktiveret koagulationstid (ACT) Op til 24 timer
Activated clotting time (ACT) Up to 24 hours
Aktiveret partiel tromboplastintid (aPTT) Op til 120 timer
Activated partial thromboplastin time (aPTT) Up to 120 hours
Aktiveret renin-angiotensin-aldosteronsystem (RAAS)
Activated renin-angiotensin-aldosterone system (RAAS)
Aktivering af infektion (tuberkulose, svampe- og virusinfektioner herunder herpes).
Activation of infection (tuberculosis, fungal and viral infections including herpes).
Aktivering af lilla 20 mikrogram pen
Purple 20 microgram pen activation
Aktivering af PPARα medfører ligeledes en stigning i syntesen af apoprotein A-I og A-II og af HDL-kolesterol.
Activation of PPARα also induces an increase in the synthesis of Apoproteins A-I, A-II and of HDL cholesterol.
Aktivering sker for at sikre, at pennen fungerer korrekt, og at dosis til din første injektion er korrekt.
Activation is done to make sure that the pen is working correctly and that the dose for your first injection is correct.
Aktiveringsdato
Date of activation
Aktiveringsklips
Syringe guard wings
Aktivitet af andre proteasehæmmere for isolater, som udviklede voksende resistens mod lopinavir efter behandling med Kaletra hos proteasehæmmer-erfarne-patienter: Tilstedeværelse af krydsresistens mod andre proteasehæmmere blev analyseret i 18 rebound-isolater, som havde vist udvikling af resistens mod lopinavir under 3 fase II- og et fase III- studie med Kaletra i proteasehæmmer-erfarne-patienter.
Activity of other protease inhibitors against isolates that developed incremental resistance to lopinavir after Kaletra therapy in protease inhibitor experienced patients: The presence of cross resistance to other protease inhibitors was analysed in 18 rebound isolates that had demonstrated evolution of resistance to lopinavir during 3 Phase II and one Phase III studies of Kaletra in protease inhibitor- experienced patients.
Aktivitet af andre proteasehæmmere for isolater, som udviklede voksende resistens mod lopinavir efter behandling med Kaletra hos proteasehæmmer-erfarne-patienter: Tilstedeværelse af krydsresistens mod andre proteasehæmmere blev analyseret i 18 rebound-isolater, som havde vist udvikling af resistens mod lopinavir under 3 fase II- og et fase III- studier med Kaletra i proteasehæmmer-erfarne-patienter.
Activity of other protease inhibitors against isolates that developed incremental resistance to lopinavir after Kaletra therapy in protease inhibitor experienced patients: The presence of cross resistance to other protease inhibitors was analysed in 18 rebound isolates that had demonstrated evolution of resistance to lopinavir during 3 Phase II and one Phase III studies of Kaletra in protease inhibitor- experienced patients.
Aktivitet mod specifikke patogener
Activity against specific pathogens
Aktivitet: {XXX} MBq i {XX} mL
Activity: {XXX} MBq in {XX} mL
Aktivitet: {Y} MBq i {Z}ml
Activity: {Y} MBq in {Z}mL
Aktivitet: {Y}________GBq/hætteglas Kundekode:
Activity: {Y} GBq/vial Client code:
AKTIVITET: …GBq/hætteglas ART: {DD/MM/ÅÅÅÅ 12:00 CET}
ACTIVITY: …GBq/vial ART: {DD/MM/YYYY 12:00 CET }
Aktiviteten af ACOMPLIA forøges ved samtidig anvendelse af visse lægemidler (såkaldte CYP3A4 - hæmmere) såsom:
The activity of ACOMPLIA is increased by simultaneous use of some drugs (so-called CYP3A4 inhibitors) such as:
Aktiviteten af dasabuvir blev reduceret med henholdsvis 5 og 11 gange af C316N- og S556G-substitutioner, 46 gange af M414T- eller Y448H-substitutioner og 1.569 gange af C316Y- substitutioner i genotype 1b-replikonen.
The activity of dasabuvir was reduced by 5- and 11-fold by C316N and S556G, respectively; 46-fold by M414T or Y448H; and 1569-fold by the C316Y substitutions in the genotype 1b replicon.
Aktiviteten af de vigtigste metabolitter, 6-beta-hydroxy-budesonid og 16-alfa-hydroxy-prednisolon, er mindre end 1 % af budesonids.
The glucocorticosteroid activity of the major metabolites, 6-beta-hydroxy-budesonide and 16-alfa-hydroxy- prednisolone, is less than 1% of that of budesonide.
Aktiviteten af GLP-1 og GIP begrænses af DPP- 4-enzymet, som hurtigt hydrolyserer inkretinhormonerne til inaktive produkter.
The activity of GLP-1 and GIP is limited by the DPP-4 enzyme, which rapidly hydrolyzes the incretin hormones to produce inactive products.
Aktiviteten af IntronA udtrykkes i IE, med 1 mg af rekombinant interferon alfa-2b protein svarende til 2,6 x 108 IE.
The activity of IntronA is expressed in terms of IU, with 1 mg of recombinant interferon alfa-2b protein corresponding to 2.6 x l08 IU.
Aktiviteten af paritaprevir blev reduceret med 96 gange af D168V-substitutionen og med 50-219 gange af hver af de andre D168- substitutioner.
The activity of paritaprevir was reduced 96-fold by D168V, and 50- to 219-fold by each of the other D168 substitutions.
Aktiviteten af stavudin påvirkes også af multiresistensassocierede mutationer såsom
The activity of stavudine is also affected by multi-drug resistance associated mutations such as Q151M.
Aktiviteten af Viraferon udtrykkes i IE, med 1 mg af rekombinant interferon alfa-2b protein svarende til 2,6 x 108 IE.
The activity of Viraferon is expressed in terms of IU, with 1 mg of recombinant interferon alfa-2b protein corresponding to 2.6 x l08 IU.
Aktiviteten af ZIMULTI forøges ved samtidig anvendelse af visse lægemidler (såkaldte CYP3A4 - hæmmere) såsom:
The activity of ZIMULTI is increased by simultaneous use of some drugs (so-called CYP3A4 inhibitors) such as:
Aktiviteten kan måles ved hjælp af et ionise- ringskammer.
Activity may be measured using an ionisation chamber.
Aktiviteten pr. ampul er 300-3000 MBq på datoen og tidspunktet for kalibrering.
The activity per vial ranges from 300 MBq to 3000 MBq at the date and time of calibration.
Aktiviteten pr. hætteglas ligger fra 1.900 MBq til 28.500 MBq på datoen og tidspunktet for kalibrering.
The activity per vial ranges from 1900 MBq to 28500 MBq at the date and time of calibration.
Aktiviteten pr. hætteglas ligger fra 800 MBq til 12.000 MBq på datoen og tidspunktet for kalibrering.
The activity per vial ranges from 800 MBq to 12000 MBq at the date and time of calibration.
Aktivitetsniveauet i knoglerne var mellem 44 % til 77 % 4 timer efter injektionen.
The level of activity in the bone was in the range of 44% to 77% at 4 hours post injection.
AKTIVT INDHOLD
STATEMENT OF ACTIVE AND OTHER SUBSTANCES
Aktivt indholdsstof :
Active substance :
Aktivt indholdsstof: Aktive stoffer
Active substance:
Aktivt indholdsstof: cobimetinib.
The active substance is cobimetinib.
Aktivt indholdsstof: pregabalin.
The active substance is pregabalin.
Aktivt indholdsstof: Telithromycin
Active substance: Telithromycin
Aktivt kontrollerede studier med patienter, som ikke responderer på monoterapi
Active-controlled trials in patients who were non-responders to monotherapy
Aktivt kontrolleret studie versus insulin glargin som tillæg til metformin  sulfonylurinstof
Active-controlled study versus insulin glargine as add-on to metformin  sulphonylurea
Aktivt kontrolleret studie versus liraglutid i kombination med metformin, thiazolidindion eller sulfonylurinstof (som monoterapi eller 2-stof-behandling)
Active-controlled study versus liraglutide in combination with metformin, thiazolidinedione, or sulphonylurea (as monotherapy or dual therapy)
Aktivt kul
Activated charcoal
Aktivt mave- og/eller duodenalsår.
Active gastric and/or duodenal ulceration,
Aktivt peptisk ulcus eller gastrointestinal (GI) blødning.
Active peptic ulceration or (GI) gastrointestinal bleeding.
Aktivt stof (Aktive stoffer):
Active substance(s)
Aktivt stof er degarelix.
The active substance is degarelix.
Aktivt stof er rivastigmin-hydrogentartrat.
The active substance is rivastigmine hydrogen tartrate.
Aktivt stof er rivastigminhydrogentartrat.
The active substance is rivastigmine hydrogen tartrate.
Aktivt stof er tobramycin.
The active substance is tobramycin.
Aktivt stof er; perflutren.
The active substance is perflutren.
Aktivt stof human insulin.
The active substance is insulin human.
Aktivt stof i 1 dosis (0,5 ml) Fendrix:
The active substance in 1 dose (0.5 ml) of Fendrix is:
Aktivt stof i Benepali: etanercept.
The active substance in Benepali is etanercept.
Aktivt stof i KIOVIG: Humant normalt immunglobulin.
The active substance of KIOVIG is human normal immunoglobulin.
Aktivt stof i Zonegran: zonisamid.
The active substance in Zonegran is zonisamide.
Aktivt stof Meloxicam 15 mg
Meloxicam 15 mg
Aktivt stof Meloxicam 5 mg
Meloxicam 5 mg
Aktivt stof vareniclin
The active substance is varenicline
Aktivt stof/aktive stoffer: fibrinogen fra humant plasma og humant thrombin.
The active substances in Raplixa are human plasma derived fibrinogen and human thrombin.
Aktivt stof/aktive stoffer: human koagulationsfaktor X. Et hætteglas indeholder normalt 250 IE eller 500 IE human koagulationsfaktor X.
The active substance is human coagulation factor X. One vial contains nominally 250 IU or 500 IU human coagulation factor X.
Aktivt stof/aktive stoffer: melatonin.
The active substance is melatonin.
Aktivt stof/aktive stoffer: naltrexonhydrochlorid og bupropionhydrochlorid.
The active substances are naltrexone hydrochloride and bupropion hydrochloride.
Aktivt stof/aktive stoffer: zoledronsyre.
The active substance is zoledronic acid.
Aktivt stof:
Active substance(s)
Aktivt stof:
Active substance(s):
Aktivt stof:
The active substance is :
Aktivt stof: (i pulveret i hætteglasset) er koncentrat af proteolytiske enzymer oprenset i bromelain: 2 g, svarende til 0,09 g/g koncentrat af proteolytiske enzymer oprenset i bromelain efter blanding.
The active substance (in the powder in the vial) is concentrate of proteolytic enzymes enriched in bromelain: 2 g, corresponding to 0.09 g/g concentrate of proteolytic enzymes enriched in bromelain after mixing.
Aktivt stof: (i pulveret i hætteglasset) er koncentrat af proteolytiske enzymer oprenset i bromelain: 5 g, svarende til ,09 g/g koncentrat af proteolytiske enzymer oprenset i bromelain efter blanding.
The active substance (in the powder in the vial) is concentrate of proteolytic enzymes enriched in bromelain: 5 g, corresponding to 0.09 g/g concentrate of proteolytic enzymes enriched in bromelain after mixing.
Aktivt stof: 13C-urea.
The active substance is 13C-urea.
Aktivt stof: 13C-urinstof
The active substance is 13C-urea.
Aktivt stof: 20 mg drotrecogin alfa (aktiveret) i hvert hætteglas.
The active substance is 20 mg of drotrecogin alfa (activated) in each vial.
Aktivt stof: 300.000-1.200.000 af dine levende øjenceller, af hvilket 3,5 % gennemsnitligt er stamceller.
The active substance consists of 300,000 - 1,200,000 of your living eye cells, on average 3.5% of which are stem cells.
Aktivt stof: 5 mg desloratadin
The active substance is 5 mg desloratadine.
Aktivt stof: 5 mg drotrecogin alfa (aktiveret) i hvert hætteglas.
The active substance is 5 mg of drotrecogin alfa (activated) in each vial.
Aktivt stof: 5-aminolevulinsyre (som hydrochlorid).
The active substance is 5-aminolaevulinic acid (as hydrochloride).
Aktivt stof: abirateronacetat.
The active substance is abiraterone acetate.
Aktivt stof: aclidiniumbromid.
The active substance is aclidinium bromide.
Aktivt stof: adalimumab
Active substance: adalimumab
Aktivt stof: adefovirdipivoxil.
The active substance in Hepsera is adefovir dipivoxil.
Aktivt stof: afamelanotid.
The active substance is afamelanotide.
Aktivt stof: afatinib.
The active substance is afatinib.
Aktivt stof: aflibercept.
The active substance is aflibercept.
Aktivt stof: Aflibercept.
The active substance is: aflibercept.
Aktivt stof: agalsidase alfa.
The active substance is agalsidase alfa.
Aktivt stof: agalsidase beta, 1 hætteglas indeholder 5 mg.
The active substance is agalsidase beta, one vial contains 5 mg.
Aktivt stof: Agomelatin.
The active substance is agomelatine.
Aktivt stof: albiglutid.
The active substance is albiglutide.
Aktivt stof: alemtuzumab
The active substance is alemtuzumab.
Aktivt stof: alfa-1-proteinasehæmmer.
The active substance is alpha1-proteinase inhibitor.
Aktivt stof: alirocumab.
The active substance is alirocumab.
Aktivt stof: aliskiren (som hemifumarat) 150 mg.
The active substance is aliskiren (as hemifumarate) 150 mg.
Aktivt stof: aliskiren (som hemifumarat) 300 mg.
The active substance is aliskiren (as hemifumarate) 300 mg.
Aktivt stof: aliskiren (som hemifumarat).
The active substance is aliskiren (as hemifumarate).
Aktivt stof: alogliptin.
The active substance is alogliptin.
Aktivt stof: Ambrisentan
The active substance is ambrisentan.
Aktivt stof: amifampridin.
The active substance is amifampridine.
Aktivt stof: anakinra.
The active substance is anakinra.
Aktivt stof: anidulafungin.
The active substance is anidulafungin.
Aktivt stof: apixaban.
The active substance is apixaban.
Aktivt stof: apremilast.
The active substance is apremilast.
Aktivt stof: Aprepitant.
The active substance is aprepitant.
Aktivt stof: aripiprazol
The active substance is aripiprazole.
Aktivt stof: arsentrioxid 1 mg/ml.
The active substance is arsenic trioxide 1 mg/ml
Aktivt stof: Asenapin.
The active substance is asenapine.
Aktivt stof: asparaginase.
The active substance is asparaginase.
Aktivt stof: atazanavir.
The active substance is atazanavir.
Aktivt stof: atosiban.
The active substance is atosiban.
Aktivt stof: autolog CD34+-beriget cellefraktion, som indeholder CD34+-celler transduceret med retroviral vektor, som koder for den humane ADA-cDNA-sekvens.
The active substance is autologous (the patient’s own) CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence.
Aktivt stof: axitinib.
The active substance is axitinib.
Aktivt stof: azacitidin.
The active substance is azacitidine.
Aktivt stof: azilsartan medoxomil (som kalium) enten 20 mg, 40 mg eller 80 mg
The active substance is azilsartan medoxomil (as potassium) either 20 mg, 40 mg or 80 mg
Aktivt stof: azilsartan medoxomil (som kalium).
The active substance is azilsartan medoxomil (as potassium).
Aktivt stof: basiliximab.
The active substance is basiliximab.
Aktivt stof: Bazedoxifen.
The active substance is bazedoxifene.
Aktivt stof: bedaquilin.
The active substance is bedaquiline.
Aktivt stof: belimumab.
The active ingredient is belimumab.
Aktivt stof: besilesomab (antigranulocyt-monoklonalt antistof fra mus).
The active substance is besilesomab (anti-granulocyte monoclonal antibody from mouse origin).
Aktivt stof: Bimatoprost.
The active substance is bimatoprost.
Aktivt stof: bivalirudin.
The active substance is bivalirudin.
Aktivt stof: blinatumomab.
The active substance is blinatumomab.
Aktivt stof: boceprevir.
The active substance is boceprevir.
Aktivt stof: bosentan som monohydrat.
The active substance is bosentan as monohydrate.
Aktivt stof: brimonidin.
The active substance is brimonidine.
Aktivt stof: brinzolamid 10 mg/ml.
The active substance is brinzolamide.
Aktivt stof: bromfenac.
The active substance is bromfenac.
Aktivt stof: Busulfan.
The active substance is busulfan.
Aktivt stof: C1-hæmmer fremstillet fra plasma fra humane dononer.
The active substance is C1 inhibitor produced from the plasma of human donors.
Aktivt stof: canagliflozin.
The active substance is canagliflozin.
Aktivt stof: canakinumab.
The active substance is canakinumab.
Aktivt stof: cangrelor.
The active ingredient is cangrelor.
Aktivt stof: capecitabin.
The active substance is capecitabine.
Aktivt stof: carfilzomib.
The active substance is carfilzomib.
Aktivt stof: cargluminsyre.
The active substance is carglumic acid.
Aktivt stof: caspofungin.
The active substance is caspofungin.
Aktivt stof: catumaxomab (10 mikrogram i 0,1 ml svarende til 0,1 mg/ml).
The active substance is catumaxomab (10 micrograms in 0.1 ml, corresponding to 0.1 mg/ml).
Aktivt stof: catumaxomab (50 mikrogram i 0,5 ml svarende til 0,1 mg/ml).
The active substance is catumaxomab (50 micrograms in 0.5 ml, corresponding to 0.1 mg/ml).
Aktivt stof: celecoxib.
The active substance is celecoxib
Aktivt stof: certolizumab pegol.
The active substance is certolizumab pegol.
Aktivt stof: Cetrorelixacetat.
The active substance is cetrorelix acetate.
Aktivt stof: cetuximab.
The active substance is cetuximab.
Aktivt stof: cholsyre.
The active substance is cholic acid.
Aktivt stof: Choriongonadotropin alfa, fremstillet ved rekombinant DNA-teknologi.
The active substance is choriogonadotropin alfa, produced by recombinant DNA technology.
Aktivt stof: ciclosporin.
The active substance is ciclosporin.
Aktivt stof: cinacalcet.
The active substance is cinacalcet.
Aktivt stof: cladribine.
The active substance is cladribine.
Aktivt stof: colesevelam (som hydrochlorid).
The active substance is colesevelam (as hydrochloride).
Aktivt stof: colestilan
The active substance is colestilan.
Aktivt stof: corifollitropin alfa.
The active substance is corifollitropin alfa.
Aktivt stof: Cytarabin.
The active substance is cytarabine.
Aktivt stof: dabrafenib.
The active substance is dabrafenib.
Aktivt stof: dalbavancin.
The active substance is dalbavancin.
Aktivt stof: dapagliflozin.
The active substance is dapagliflozin.
Aktivt stof: daptomycin.
The active substance is daptomycin.
Aktivt stof: daratumumab.
The active substance is daratumumab.
Aktivt stof: darbepoetin alfa, r-HuEPO (erythropoietin produceret ved hjælp af genteknologi).
The active substance is darbepoetin alfa, r-HuEPO (erythropoietin produced by gene technology).